Alerts & Newsletters

By providing your information, you agree to our Terms of Use and our Privacy Policy. We use vendors that may also process your information to help provide our services. This site is protected by reCAPTCHA Enterprise and the Google Privacy Policy and Terms of Service apply.

Merry Christmas Box Office for ‘Phantom Thread,’ ‘The Post,’ and ‘Lady Bird’

It's the year's most competitive weekend for specialized film, but the holidays accommodated multiple winners.
"Phantom Thread"
"Phantom Thread"

Post-Christmas weekend is often the year’s biggest for specialized films, rivaled only by the one after Oscar nominations. This year, an unusually large number of titles competed for limited screens including Paul Thomas Anderson’s “Phantom Thread” (very limited) and Aaron Sorkin’s “Molly’s Game” (national, but only in 255 theaters), with better than predicted results.

Responses were less impressive for “Film Stars Don’t Die in Liverpool” and German Oscar contender “In the Fade,” which saw mediocre New York/Los Angeles openings.

Steven Spielberg’s “The Post” is still the top limited performer, maintaining its strong presence in its second weekend in nine theaters. Among wider film, “Darkest Hour” scored a Top 10 placement overall and “The Shape of Water” just missed in its still less-than-wide run.

Standing out as well is “Lady Bird,” which is rebounding strongly over the holidays and looks poised for more as it continues to get major awards attention.

Opening

Phantom Thread (Focus) – Metacritic: 92

$220,000 in 4 theaters; PTA (per theater average): $54,794; Cumulative: $616,000

With its Monday opening, this is a full-week gross averaging $154,000, very strong by any definition. Some context: The first three days, including its Christmas opening, averaged $252,000. And Paul Thomas Anderson’s films, of which this is one of the most acclaimed, have a history of strong platform runs. “Inherent Vice,” with a five-theater, pre-Christmas opening, had a PTA of $65,000. “The Master” was even stronger, with an incredible $147,000 initial average.

Both of his previous films opened with far less specialized competition and more seats, but it remains too early to project the future for this. Unlike either one of those films, this will have the benefit of a major boost from expected Oscar nominations around the time of its national release.

What comes next: The national release comes on January 19.

“Molly’s Game”

Molly’s Game (STX) – Metacritic: 71; Festivals include: Toronto, AFI 2017

$2,330,000 in 271 theaters; PTA: $8,598; Cumulative: $5,220,000

Jessica Chastain’s hopes for a Best Actress nomination should be helped by the profile of this limited national release. Aaron Sorkin’s directorial debut scored a decent response in a cross-country big city and suburban upscale release, with over $5 million already in after its Christmas Day opening.

What comes next: STX will get a jump on other late openers with a 1,500 theater break this Friday.

Film Stars Don’t Die in Liverpool (Sony Pictures Classics) – Metacritic: 66; Festivals include: Telluride, Toronto 2017

$36,048 in 4 theaters; PTA: $9,012

The last opening of 2017 is timed for getting Annette Bening maximum attention in hopes of a Best Actress nomination. It’s a tricky date to open, though it can lead to awards attention that helps with later dates.

Last year, A24 opened “20th Century Woman,” also with Bening, on December 28 (a Wednesday), with a weekend gross of $111,000 in four theaters ($178,000 for five days). That’s much better than the result for this story of actress Gloria Grahame and her affair with a much-younger English actor.

What comes next: The slow national limited expansion with high-level marketing will parallel the possible nomination for Bening.

“In the Fade”

In the Fade (Magnolia) – Metacritic: 62; Festivals include: Cannes, Toronto, Hamptons 2017

$(est.) 9,800 in 3 theaters; PTA: $(est.) 3,233; Cumulative: $(est.) 17,500

Turkish native Fatih Akin has made most of his films in Germany, where he has become one of its best-known directors. His latest is that country’s Oscar submission, and made the semi-finalist list of nine. The release is not needed for qualifying for that, but is timed to elevate awareness for the final stage. Initial response for this drama about a woman’s response to events after her husband and son are killed by right-wing terrorists is not encouraging after its Wednesday release in New York and Los Angeles at three top theaters. The opening does put Diane Kruger, who has garnered strong reviews, into Best Actress consideration.

What comes next: A wave of limited dates timed to benefit from any Oscar attention.

“The Post”Courtesy of 20th Century Fox

Week Two

The Post (20th Century Fox)

$539,440 in 9 theaters (no change); PTA: $59,938; Cumulative: $1,738,000

A slight increase from its opening weekend at the same nine New York/Los Angeles/Washington locations. Steven Spielberg’s retelling of the drama surrounding the publication of the Pentagon Papers in 1971 continues to be the best late-entry platform release, although “Phantom Thread” (in only four theaters) still has a higher PTA. These aren’t extraordinary numbers; “American Sniper” three years ago had an average of $158,000 on its initial weekend in four theaters. But in a very competitive period for the same older audience, more sophisticated viewers, and a broader group of locations, this is a strong result ahead of its wide national break on January 12.

Hostiles (Entertainment Studios)

$(est.) 35,000 in 5 theaters (+2); PTA: $(est.) 7,000; Cumulative: $(est.) 98,000

Though the limited-run grosses for Scott Cooper’s Western starring Christian Bale remain muted, they did improve this weekend. Also, this had few or no newspaper ads running, making the uptick even more intriguing. This will add additional limited run next Friday and go national January 12.

"Happy End" Michael Haneke Isabelle Huppert
“Happy End”Les Films du Losange

Happy End (Sony Pictures Classics)

$15,466 in 3 theaters (no change); PTA: $5,155; Cumulative: $60,125

The second weekend in prime New York/Los Angeles theaters for Michael Haneke’s first film since his breakout “Amour” dropped about a third its second weekend. That isn’t unusual despite the holiday weekend, but does put the film at a level consistent with the struggles of so many top subtitled films these days.

 

Ongoing/expanding (Grosses over $50,000)

The Darkest Hour (Focus) Week 6

$5,280,000 in 943 theaters (+137); Cumulative: $19,812,000

A very good 36 percent uptick for Joe Wright’s Churchill 1940 drama. This has the best three-day total for any specialized release this year other than “The Big Sick.” Focus has done a terrific job of maximizing this title, positioning it to reach its older audience right when they pay the most attention.

Sally Hawkins and Richard Jenkins in the film THE SHAPE OF WATER. Photo by Kerry Hayes. © 2017 Twentieth Century Fox Film Corporation All Rights Reserved
“The Shape of Water”Kerry Hayes

The Shape of Water (Fox Searchlight) Week 5

$3,490,000 in 756 theaters (+30); Cumulative: $15,630,000

A healthy increase of 16 percent over last week, with most theaters having played at least two weeks. Guillermo del Toro’s science-fiction romantic fantasy/thriller is already having early success with a much wider release, putting it in position to match or exceed “Darkest Hour” and “Lady Bird.”

Lady Bird (A24) Week 9

$1,426,000 in 392 theaters (-10); Cumulative: $31,392,000

A better than 40 percent increase for Greta Gerwig’s coming of age film. Though it lost theaters during the holidays, and some theaters don’t have complete schedules, the current surge is showing a real depth of strength for the film as it goes into the heart of awards season. This has had the best word-of-mouth boost of any late fall/early winter release. It has nominations ahead to give it more of a push, with at least $40 million likely and a chance to be the top specialized release from 2017 (currently “The Big Sick” at $43 million).

The Disaster Artist (A24) Week 5

$951,982 in 507 theaters (-10); Cumulative: $17,881,000

A decent eight percent jump over last weekend for James Franco’s film, which already had made a pre-holiday impact.

Call Me By Your Name
“Call Me by Your Name”

Call Me By Your Name (Sony Pictures Classics) Week 6

$702,098 in 115 theaters (+1); Cumulative: $4,611,000

The biggest boost lies ahead for Luca Guadagnino’s acclaimed gay romantic drama; Oscar nominations place it among the forefront of contenders. In the meantime it is shows continued interest and adds to an early decent total, although it did show a small drop from last weekend.

Three Billboards Outside Ebbing, Missouri (Fox Searchlight) Week 8

$665,000 in 266 theaters (-41); Cumulative: $24,154,000

Up 21 percent, despite a loss of theaters.

I, Tonya (Neon) Week 4

$661,603 in 49 theaters (+7); Cumulative: $2,662,000

A few more theaters added is only a small part of the very impressive 60 percent increase for the still-limited run of this retelling of the Tonya Harding/Nancy Kerrigan Olympic rivalry.

The Man Who Invented Christmas (Bleecker Street) Week 6

$67,017 in 146 theaters (no change); Cumulative: $5,579,000

Christmas comes but once a year, which hasn’t been much help for this story of Charles Dickens creating “A Christmas Carol.”

 

Also noted:

The Florida Project (A24)  – $46,680 in 33 theaters; Cumulative: $5,294,000

Loving Vincent (Good Deed) – $(est.) 45,000 in theaters; Cumulative: $(est.) 6,219,000

Jane (Abramorama) – $26,000 in 21 theaters; Cumulative: $1,492,000

Victoria & Abdul (Focus) – $20,000 in 23 theaters; Cumulative: $22,240,000

Faces Places (Cohen) – $11,508 in theaters; Cumulative: $604,594

Daily Headlines
Daily Headlines covering Film, TV and more.

By providing your information, you agree to our Terms of Use and our Privacy Policy. We use vendors that may also process your information to help provide our services. This site is protected by reCAPTCHA Enterprise and the Google Privacy Policy and Terms of Service apply.

Must Read
PMC Logo
IndieWire is a part of Penske Media Corporation. © 2024 IndieWire Media, LLC. All Rights Reserved.